Published: January 7th, 2021 The vice chair and head of M&A discusses building the firm's biotech practice, helping Covid-19 vaccine developer Moderna grow over the years and recent transformational deals in the latest episode of the podcast. Stuart Cable and his colleagues at Goodwin Procter LLP in Boston saw the biotechnology sector emerging across the Charles River in Cambridge, Mass., about 15 years ago, and they set out to build a law firm that could serve it. That required developing a team of highly specialized lawyers who could work on issues faced by biotech companies ranging in size from startups to multibillion-dollar public companies, Cable says in this week’s Drinks With The Deal podcast.